Gui-zhen Wang
State Key Laboratory Of Molecular Oncology And Department Of Internal Medicine, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Structure-Based Virtual Screening of New Skp1 Inhibitor Chemotypes Targeting F-Box Binding Interface.
Journal: Drug design, development and therapy
Published: October 31, 2025
A splicing alternative of REST in neuroendocrine neoplasms of the lung and breast.
Journal: Cancer letters
Published: June 19, 2025
Smohaze-Upregulated RFWD3 Competes with TRIM24 to Stabilize TREX1 and Reduce Cytosolic dsDNA in Non-Small Cell Lung Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 10, 2025
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers.
Journal: Signal transduction and targeted therapy
Published: February 07, 2025
PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade.
Journal: Cell biology and toxicology
Published: December 05, 2023
Air pollution, EGFR mutation, and cancer initiation.
Journal: Cell reports. Medicine
Published: April 18, 2023
Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade.
Journal: Signal transduction and targeted therapy
Published: September 27, 2022
Author Correction: The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy.
Journal: Nature communications
Published: June 22, 2022
Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.
Journal: Signal transduction and targeted therapy
Published: March 04, 2022
Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer.
Journal: Frontiers in oncology
Published: December 12, 2021
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.
Journal: Signal transduction and targeted therapy
Published: August 09, 2021
Last Updated: 09/26/2026